Lee D, Gimple R, Wu X, Prager B, Qiu Z, Wu Q
J Clin Invest. 2022; 133(2).
PMID: 36394953
PMC: 9843063.
DOI: 10.1172/JCI163592.
Kandel N, Wang C
Front Mol Biosci. 2022; 9:900560.
PMID: 35669560
PMC: 9163320.
DOI: 10.3389/fmolb.2022.900560.
Oh J, Rajendran R, Gangadaran P, Hong C, Jeong J, Lee J
Cancers (Basel). 2022; 14(7).
PMID: 35406554
PMC: 8997411.
DOI: 10.3390/cancers14071782.
Keyvani-Ghamsari S, Khorsandi K, Rasul A, Zaman M
Clin Epigenetics. 2021; 13(1):120.
PMID: 34051847
PMC: 8164819.
DOI: 10.1186/s13148-021-01107-4.
Espinosa-Sanchez A, Suarez-Martinez E, Sanchez-Diaz L, Carnero A
Front Oncol. 2020; 10:1533.
PMID: 32984007
PMC: 7479251.
DOI: 10.3389/fonc.2020.01533.
Hedgehog Signaling and Truncated GLI1 in Cancer.
Doheny D, Manore S, Wong G, Lo H
Cells. 2020; 9(9).
PMID: 32957513
PMC: 7565963.
DOI: 10.3390/cells9092114.
Combined inhibition of JAK2-STAT3 and SMO-GLI1/tGLI1 pathways suppresses breast cancer stem cells, tumor growth, and metastasis.
Doheny D, Sirkisoon S, Carpenter R, Aguayo N, Regua A, Anguelov M
Oncogene. 2020; 39(42):6589-6605.
PMID: 32929154
PMC: 7572897.
DOI: 10.1038/s41388-020-01454-1.
Patched homolog 1 (PTCHI) gene mutations can predict the outcome of chronic myeloid leukemia patients?.
Elrhman H, Ebian H
Am J Blood Res. 2019; 9(2):15-24.
PMID: 31316860
PMC: 6627272.
CDK7 inhibition suppresses aberrant hedgehog pathway and overcomes resistance to smoothened antagonists.
Liu F, Jiang W, Sui Y, Meng W, Hou L, Li T
Proc Natl Acad Sci U S A. 2019; 116(26):12986-12995.
PMID: 31182587
PMC: 6600918.
DOI: 10.1073/pnas.1815780116.
Role of Hedgehog Signaling in Breast Cancer: Pathogenesis and Therapeutics.
Riobo-Del Galdo N, Lara Montero A, Wertheimer E
Cells. 2019; 8(4).
PMID: 31027259
PMC: 6523618.
DOI: 10.3390/cells8040375.
Safety and Tolerability of Sonic Hedgehog Pathway Inhibitors in Cancer.
Carpenter R, Ray H
Drug Saf. 2019; 42(2):263-279.
PMID: 30649745
PMC: 6434684.
DOI: 10.1007/s40264-018-0777-5.
Developmental phosphoproteomics identifies the kinase CK2 as a driver of Hedgehog signaling and a therapeutic target in medulloblastoma.
Purzner T, Purzner J, Buckstaff T, Cozza G, Gholamin S, Rusert J
Sci Signal. 2018; 11(547).
PMID: 30206138
PMC: 6475502.
DOI: 10.1126/scisignal.aau5147.
Metachronous Development of Meningothelial Meningioma, Basal Cell Carcinoma, and Glioblastoma Multiforme in a Patient with Pancreatic Incidentaloma.
Naydenov E, Bussarsky V, Angelov K, Penkov M, Nachev S, Hadjidekova S
Case Rep Oncol. 2017; 10(3):1023-1028.
PMID: 29279708
PMC: 5731176.
DOI: 10.1159/000484404.
Sonic Hedgehog Signaling in Thyroid Cancer.
Xu X, Lu Y, Li Y, Prinz R
Front Endocrinol (Lausanne). 2017; 8:284.
PMID: 29163356
PMC: 5670164.
DOI: 10.3389/fendo.2017.00284.
New paradigms for the Hedgehog signaling network in mammary gland development and breast Cancer.
Monkkonen T, Lewis M
Biochim Biophys Acta Rev Cancer. 2017; 1868(1):315-332.
PMID: 28624497
PMC: 5567999.
DOI: 10.1016/j.bbcan.2017.06.003.
Development of anticancer agents targeting the Hedgehog signaling.
Zhang X, Tian Y, Yang Y, Hao J
Cell Mol Life Sci. 2017; 74(15):2773-2782.
PMID: 28314894
PMC: 11107598.
DOI: 10.1007/s00018-017-2497-x.
The hedgehog pathway in triple-negative breast cancer.
Habib J, OShaughnessy J
Cancer Med. 2016; 5(10):2989-3006.
PMID: 27539549
PMC: 5083752.
DOI: 10.1002/cam4.833.
Targeting of sonic hedgehog-Gli signaling: A potential therapeutic target for patients with breast cancer.
Song L, Wang W, Liu D, Zhao Y, He J, Wang X
Oncol Lett. 2016; 12(2):1027-1033.
PMID: 27446389
PMC: 4950736.
DOI: 10.3892/ol.2016.4722.
Evaluation of the 'Hedgehog' signaling pathways in squamous and basal cell carcinomas of the eyelids and conjunctiva.
Celebi A, Kiratli H, Soylemezoglu F
Oncol Lett. 2016; 12(1):467-472.
PMID: 27347166
PMC: 4907170.
DOI: 10.3892/ol.2016.4625.
The C-terminal cytoplasmic tail of hedgehog receptor Patched1 is a platform for E3 ubiquitin ligase complexes.
Yamaki Y, Kagawa H, Hatta T, Natsume T, Kawahara H
Mol Cell Biochem. 2016; 414(1-2):1-12.
PMID: 26885983
DOI: 10.1007/s11010-015-2643-4.